TipRanks
Go Ultimate55% OFF

Lucid Diagnostics (LUCD) Stock Forecast & Price Target

616 Followers
See the Price Targets and Ratings of:

LUCD Analyst Ratings

Strong Buy
5Ratings
5Buy0Hold0Sell
Based on 5 analysts giving stock ratings to Lucid Diagnostics in the past 3 months

LUCD Stock 12 Month Forecast

$4.00▲(798.88% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Lucid Diagnostics in the last 3 months. The average price target is $4.00 with a high forecast of $9.50 and a low forecast of $2.00. The average price target represents a 798.88% change from the last price of $0.44.
Highest Price Target$9.50Average Price Target$4.00Lowest Price Target$2.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for LUCD
Price TargetFollowArticle
Maxim Group$2buy349.44%UpsideReiterated10/26/26
Canaccord Genuity$3buy574.16%UpsideReiterated10/23/26
Needham$3buy574.16%UpsideReiterated10/01/26
Ascendiant$9.25→$9.50buy2034.83%UpsideReiterated08/26/26
BTIG$2.50buy461.80%UpsideReiterated08/17/26
Cantor Fitzgerald$3buy574.16%UpsideReiterated11/18/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
SLDBSolid Biosciences
AHCOAdaptHealth
ONCBeOne Medicines
ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lucid Diagnostics

3 Months
Kyle Mikson CFA
Kyle Mikson CFACanaccord Genuity
Success Rate6/19 ratings generated profit
32%
Average Return
-3.43%

Copying Kyle Mikson CFA's trades and holding each position for 3 Months would result in 31.58% of your transactions generating a profit, with an average return of -3.43% per trade.

1 Year
Success Rate6/28 ratings generated profit
21%
Average Return
-24.88%

Copying Michael Matson's trades and holding each position for 1 Year would result in 21.43% of your transactions generating a profit, with an average return of -24.88% per trade.

2 Years
Kyle Mikson CFA
Kyle Mikson CFACanaccord Genuity
Success Rate3/19 ratings generated profit
16%
Average Return
-42.74%

Copying Kyle Mikson CFA's trades and holding each position for 2 Years would result in 15.79% of your transactions generating a profit, with an average return of -42.74% per trade.

LUCD Analyst Recommendation Trends

05101520Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for LUCD
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy55584
Buy00000
Hold00000
Sell00000
Strong Sell00000
total55584

In the current month, LUCD has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LUCD average Analyst price target in the past 3 months is 4.00.

LUCD Financial Forecast

$-2$-1.5$-1$-0.5$0Q4 2025Q2 2026Q3 2026
High$-0.05
Consensus$-0.06
Low$-0.06

LUCD Earnings Forecast

Next quarter’s earnings estimate for LUCD is -$0.06 with a range of -$0.06 to -$0.05. The previous quarter’s EPS was -$0.06. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$1.2M$1.4M$1.5M$1.7M$1.8MQ4 2025Q2 2026Q3 2026
High$1.82M
Consensus$1.63M
Low$1.48M

LUCD Sales Forecast

Next quarter’s sales forecast for LUCD is $1.63M with a range of $1.48M to $1.82M. The previous quarter’s sales results were $1.47M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

LUCD Stock Forecast FAQ

What is LUCD’s average 12-month price target, according to analysts?
Based on analyst ratings, Lucid Diagnostics’s 12-month average price target is $4.00.
What is LUCD’s upside potential, based on the analysts’ average price target?
Lucid Diagnostics has 798.88% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LUCD a Buy, Sell or Hold?
Lucid Diagnostics has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Lucid Diagnostics’s price target?
The average price target for Lucid Diagnostics is $4.00. This is based on 5 12-month price targets, issued in the past 3 months. The highest analyst price target is $9.50, the lowest forecast is $2.00. The average price target represents a 798.88% increase from the current price of $0.445.
What do analysts say about Lucid Diagnostics?
Lucid Diagnostics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Street analysts.
How can I buy shares of LUCD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.